Keong Hong Holdings Limited (SGX:5TT)

Marinus Pharmaceuticals Revenue

Keong Hong Holdings had revenue of 122.85M SGD in the half year ending March 31, 2025, with 4.02% growth. This brings the company's revenue in the last twelve months to 213.53M, up 30.51% year-over-year. In the fiscal year ending September 30, 2024, Keong Hong Holdings had annual revenue of 172.60M, down -13.61%.

• Revenue (ttm): 213.53M
• Revenue Growth: +30.51%
• P/S Ratio: 0.22
• Revenue / Employee: 711.76K
• Employees: 300
• Market Cap: 46.77M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Sep 30, 2024	172.60M	-27.19M	-13.61%
Sep 30, 2023	199.79M	51.72M	34.93%
Sep 30, 2022	148.07M	71.12M	92.41%
Sep 30, 2021	76.95M	-5.99M	-7.22%
Sep 30, 2020	82.94M	-79.62M	-48.98%